Clinicopathologic presentations of dermatomycoses in cancer patients.

[en] Many of the skin fungal infections in cancer patients may look similar to those infections in non-cancer patients. However, in some cases, they become more extensive and even life threatening. Prolonged and severe neutropenia is the main risk factor for the dramatic issue of fungal infections. The dermatomycoses in cancer patients can be classified in four broad groups: primary superficial dermatophytoses, primary superficial yeast infections, opportunistic mold infections with distinct potential for dissemination and secondary cutaneous manifestations of fungaemia. Occasionally, more than one fungus are found inside a given skin lesion. A special condition is represented by the mycotic colonization of mucosal squamous cell carcinomas. Angio-invasion by fungi accounts for the frequency of disseminated infections prevailing in immunocompromised cancer patients. In case of skin involvement, the dermatologist may assist by recognizing subtle semiological signs and performing biopsies for swift histological examination, molecular biology and/or culture.

Disciplines :

Dermatology

Author, co-author :

Quatresooz, Pascale ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Pierard, Claudine ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Arrese Estrada, Jorge ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Pierard, Gérald ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Language :

English

Title :

Clinicopathologic presentations of dermatomycoses in cancer patients.

Publication date :

2008

Journal title :

Journal of the European Academy of Dermatology and Venereology

ISSN :

0926-9959

eISSN :

1468-3083

Publisher :

Blackwell Publishing, Oxford, United Kingdom

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 16 December 2008

Statistics

Number of views

90 (6 by ULiège)

Number of downloads

1 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Brown AE. Overview of fungal infections in cancer patients. Semin Oncol 1990 17 : 2 5.
Walsh TJ, De Pauw B, Anaissie E, Martino P. Recent advances in the epidemiology, prevention and treatment of invasive fungal infections in neutropenic patients. J Med Vet Mycol 1994 32 : S33 S51.
Quatresooz P, Arrese JE, Piérard GE. Synopsis des dermatomycoses invasives chez l'immunodéprimé. Rev Med Liège 2003 58 : 690 694.
Mays SR, Bogle MA, Bodey GP. Cutaneous fungal infections in the oncology patient. Recognition and management. Am J Clin Dermatol 2006 7 : 31 43.
Nosari A, Oreste P, Cairoli R et al. Invasive aspergillosis in haematological malignancies: clinical findings and management for intensive chemotherapy completion. Am J Hematol 2001 68 : 231 236.
Piérard GE, Arrese JE, Piérard-Franchimont C, Quatresooz P. Onychomycosis in older patients. Aging Health 2006 2 : 865 870.
Piérard GE, Piérard-Franchimont C. The nail under fungal siege in patients with type II diabetes mellitus. Mycoses 2005 48 : 339 342.
Piérard-Franchimont C, Arrese JE, Hermanns-Lê T, Piérard GE. Epidemiology of onychomycosis assessed by histomycology in psoriatic patients. J Mycol Med 2006 16 : 159 162.
Roeder A, Kirschning CJ, Rupec RA, Schaller M, Weindl G, Korting HC. Toll-like receptors as key mediators in innate antifungal immunity. Med Mycol 2004 42 : 485 498.
Tanaka S, Summerbell RC, Tsuboi R et al. Advances in dermatophytes and dermatophytosis. J Med Vet Mycol 1992 30 : S29 S39.
Tsuboi R, Ogawa H, Bramano K et al. Pathogenesis of superficial mycoses. J Med Vet Mycol 1994 32 : S91 S104.
Piérard GE, Quatresooz P, Arrese JE. Spotlight on nail histomycology. Dermatol Clin 2006 24 : 371 374.
Nir-Paz R, Elinay H, Piérard GE et al. Deep infection by Trichophyton rubrum in an immunocompromised patient. J Clin Microbiol 2003 41 : 5298 5301.
Aljabre SHM, Richardson MD, Scott EM, Shankland GS. Dormancy of Trichophyton mentagrophytes arthroconidia. J Med Vet Mycol 1992 30 : 409 412.
Arrese JE, Piérard GE. Treatment failures and relapses in onychomycosis: a stubborn clinical problem. Dermatology 2003 207 : 255 260.
Piérard GE, Piérard-Franchimont C, Arrese JE. The boosted oral antifungal treatment for onychomycosis beyond the regular itraconazole pulse dosing regimen. Dermatology 2000 200 : 185 187.
Piérard GE, Piérard-Franchimont C, Arrese JE. The boosted antifungal topical treatment (BATT) for onychomycosis. Med Mycol 2000 38 : 391 392.
Piérard GE. Spores, sporodochia and fomites in onychomycosis. Dermatology, 2006 213 : 169 172.
Piérard-Franchimont C, Piérard GE. Skin surface strippings in diagnosing and monitoring inflammatory, xerotic and neoplastic diseases. Ped Dermatol 1985 2 : 180 184.
Samdani AJ, Dykes PJ, Marks R. The effect of dermatophyte species and density of infection on the pathology of ringworm. J Med Vet Mycol 1991 29 : 279 281.
Guého E, Faergemann J, Lyman C, Anaissie EJ. Malassezia and Trichosporon: two emerging pathogenic basidiomycetous yeast-like fungi. J Med Vet Mycol 1994 32 : S367 S378.
Chakrabarti A, Marhawa RK, Mondal R et al. Generalized lymphadenopathy caused by Trichosporon asahii in a patient with Job's syndrome. Med Mycol 2002 40 : 83 86.
Gupta AK, Bluhm R. Seborrheic dermatitis. J Eur Acad Dermatol Venereol 2004 18 : 13 16.
Piérard GE, Xhauflaire-Uhoda E, Piérard-Franchimont C. The key role of corneocytes in pityrosporoses. Dermatology 2006 212 : 23 26.
Piérard-Franchimont C, Xhauflaire-Uhoda E, Piérard GE. Revisiting dandruff. Int J Cosmet Sci 2006 28 : 311 318.
Piérard GE, Read D, Piérard-Franchimont C, Lother Y, Rurangirwa A, Arresse Estrada J. Cutaneous manifestations in systemic trichosporonosis. Clin Exp Dermatol 1992 17 : 79 82.
Piérard GE, Arrese JE, Piérard-Franchimont C, Thiry A, Stynen D. Immunohistochemical expression of galactomannan in the cytoplasm of phagocytic cells during invasive aspergillosis. Am J Clin Pathol 1991 96 : 373 376.
Arrese JE, Piérard-Franchimont C, Piérard GE. Fatal hyalohyphomycosis following Fusarium onychomycosis in an immunocompromised patient. Am J Dermatopathol 1996 18 : 196 198.
Nucci M, Anaissie E. Cutaneous infections by Fusarium species in healthy and immunocompromised hosts. implications for diagnosis and management. Clin Infect Dis 2002 35 : 909 920.
Tosti A, Piraccini BM, Lorenzi S. Onychomycosis caused by nondermatophyte molds: clinical features and response to treatment of 59 cases. J Am Acad Dermatol 2000 42 : 217 224.
McCarty JM, Flam MS, Pullen G, Jones R, Kassel SH. Outbreak of primary cutaneous aspergillosis related to intravenous arm boards. J Pediatr 1986 108 : 721 724.
Allo MD, Miller J, Townsend T, Tan C. Primary cutaneous aspergillosis associated with Hickman intravenous catheters. N Engl J Med 1987 317 : 1105 1108.
Walmsley S, Devi S, King S, Schneider R, Richardson S, Ford-Jones L. Invasive Aspergillus infections in a pediatric hospital; a ten year review. Pediatr Infect Dis J 1993 12 : 673 682.
Boutati E, Anaissie E. Fusarium, a significant emerging pathogen in patients with hematologic malignancy. Blood 1997 3 : 999 1008.
Abbasi S, Shenep JL, Hughes WT, Flynn PM. Aspergillosis in children with cancer: a 34-year experience. Clin Infect Dis 1999 29 : 1210 1219.
Bodey GP, Boktour M, Mays S et al. Skin lesions associated with Fusarium infection. J Am Acad Dermatol 2002 47 : 659 666.
Piérard GE, Arrese JE, Quatresooz P. Comparative clinicopathological manifestations of human aspergillosis. A review. Exog Dermatol 2004 3 : 144 153.
Piérard GE, Kharfi M, Salomon-Neira MD, Kamoun MR, Piérard-Franchimont C. Itraconazole in human aspergillosis revisited. J Mycol Med 2004 14 : 192 200.
Flagothier C, Arrese JE, Quatresooz P, Piérard GE. Cutaneous mucormycosis. J Mycol Med 2006 16 : 77 81.
Weitzman I. Saprophytic molds as agents of cutaneous and subcutaneous infection in the immunocompromised host. Arch Dermatol 1986 122 : 1161 1168.
Iwen PC, Rupp ME, Hinrichs SH. Invasive mold sinusitis: 17 cases in immunocompromised patients and review of the literature. Clin Infect Dis 1997 24 : 1178 1184.
de Shazo RD, O'Brien M, Chapin K, Soto-Aguilar M, Gardner L, Swain R. A new classification and diagnostic criteria for invasive fungal sinusitis. Arch Otolaryngol Head Neck Surg 1997 123 : 1181 1188.
Kramer BS, Hernandez AD, Reddick RL, Levine AS. Cutaneous infarction. Manifestation of disseminated mucormycosis. Arch Dermatol 1977 113 : 1076 1076.
Rubbin AI, Grossman ME. Bull's-eye cutaneous infarct of zygomycosis: a bedside diagnosis confirmed by touch preparation. J Am Acad Dermatol 2004 51 : 996 1001.
Rolston K. Overview of systemic fungal infections. Oncology 2001 15 : S11 S14.
Pagano L, Antinori A, Ammassari A et al. Retrospective study of candidemia in patients with hematologic malignancies: clinical features, risk factors and outcome of 76 episodes. Eur J Hematol 1999 63 : 77 85.
Grossman ME, Silvers DN, Walther RR. Cutaneous manifestations of disseminated candidiasis. J Am Acad Dermatol 1980 2 : 111 116.
Darcis JM, Etienne M, Demonty J, Christophe J, Piérard GE. Candida albicans septicemia with folliculitis in heroin addicts. Am J Dermatopathol 1986 8 : 501 504.
Quatresooz P, Meiers I, Arrese J, Boniver J, Piérard GE. Fusariose disséminée chez un patient immunodéprimé. Rev Med Liège 2000 55 : 974 976.
Dignani MC, Anaissie E. Human fusariosis. Clin Microbiol Infect 2004 10 : S67 S75.
Averbuch D, Boekhout T, Falk R et al. Fungemia in a cancer patient caused by fluconazole-resistant Cryptococcus laurentii. Med Mycol 2002 40 : 479 484.
Horré R, Jovanic B, Herff S et al. Wound infection due to Absidia corymbifera and Candida albicans with fatal outcome. Med Mycol 2004 42 : 373 378.
Kimura M, Udagawa S, Toyazaki N, Iimori M, Hashimoto S. Isolation of Rhizopus microsporus var. rhizopodifoormis in the ulcer of human gastric carcinoma. J Med Vet Mycol 1995 33 : 137 139.
Rubin AI, Baheri B, Scher RK. Six novel antimycotics. Am J Clin Dermatol 2002 3 : 71 81.
Koga T, Matsuda T, Matsumoto T, Furue M. Therapeutic approaches to subcutaneous mycoses. Am J Clin Dermatol 2003 4 : 537 543.
Gupta AK, Cooper EA, Ryder JE, Nicol KA, Chow M, Chaudhry MM. Optimal management of fungal infections of the skin, hair, and nails. Am J Clin Dermatol 2004 5 : 225 237.
Baran R, Gupta AK, Piérard GE. Pharmacotherapy of onychomycosis. Expert Opin Pharmacother 2005 6 : 609 624.
Piérard-Franchimont C, Ausma J, Wouters L et al. Activity of the triazole antifungal R126638 as assessed by corneofungimetry. Skin Pharmacol Physiol 2006 19 : 49 56.
Piérard GE, Piérard-Franchimont C, Vroome V, Borgers M, Cauwenbergh G. Established and emerging oral antifungals in dermatology. In : Walters KA, Roberts MS, eds. Dermatological and Cosmeceutical Development. Publications Marcel Dekker, New York, forthcoming.